Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LSD in Major Depressive Disorder
NCT03866252Phase 2Completed
- Sponsor
- University Hospital Basel
- Start
- Nov 2019
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Lysergide in major depressive disorder (MDD), sponsored by University Hospital Basel. Started Nov 2019; status: completed.
02
Drugs
Lysergide
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03866252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03866252.